Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06620627 · ClinicalTrials.gov registry record
Prospective Collection of Samples to Enable the Development of Natera Screening Assay for Early Cancer Detection
A clinical trial of Colorectal Cancer Screening, sponsored by Natera.
- Recruiting
- Registry status
- 5,000
- Enrollment target
- 1
- Study location
NCT06620627 is a study of Colorectal Cancer Screening that is actively recruiting participants, run by Natera. The registered enrollment target is 5,000 participants, below the 5,620-participant average among 19 other Colorectal Cancer Screening trials with a reported enrollment target (11% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06620627, a study of Colorectal Cancer Screening, is actively recruiting participants, sponsored by Natera.
- RECRUITING
- Registry status
- 5,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The PROCEED-CRC study will prospectively collect blood samples from participants who are at average risk of colorectal cancer (CRC). Samples will be used for research use and the development of a blood-based CRC screening test.
Conditions Studied
Study Locations (1)
Texas
- Natera - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2024-01-26 |
| Est. Completion | 2025-10-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06620627
The ClinicalTrials.gov registry entry for NCT06620627 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 5,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,620-participant average among 19 other Colorectal Cancer Screening trials with a reported enrollment target (11% lower). The listed sponsor is Natera, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Colorectal Cancer Screening appearing as the primary indexed condition, and to 0 interventions.
NCT06620627 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT06620627 about?
NCT06620627 is a clinical study titled "Prospective Collection of Samples to Enable the Development of Natera Screening Assay for Early Cancer Detection". The PROCEED-CRC study will prospectively collect blood samples from participants who are at average risk of colorectal cancer (CRC). Samples will be used for research use and the development of a blood-based CRC screening test.
What is the current status of trial NCT06620627?
This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2024-01-26. Estimated completion is 2025-10-31.
What conditions does trial NCT06620627 study?
This clinical trial studies the following conditions: Colorectal Cancer Screening.
Who is sponsoring clinical trial NCT06620627?
This trial is sponsored by Natera, which has 27 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06620627 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Cancer Screening
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Impact of Protect Your Colon™ on CRC Screening
RECRUITING · NA
-
Cleansing Options in Out-Patient Setting to Improve Tolerance (COOP SIT) Trial
RECRUITING · Phase 4
-
Use of a Colorectal Cancer Screening Decision Support Tool in Primary Care
RECRUITING · NA
-
A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer
RECRUITING
-
Effectiveness of a Cloud-based Digital Health Navigation Program for Colorectal Cancer Screening
RECRUITING · NA
-
Pilot Study for Colorectal Cancer and Advanced Adenoma Detection With the Mainz Biomed Colorectal Cancer Test
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.